Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Organ Transplant Immunosuppressant Drugs Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Organ Transplant Immunosuppressant Drugs Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Antibodies
      • 1.3.3 Antiproliferative Agents
      • 1.3.4 Calcineurin Inhibitors
      • 1.3.5 mTOR Inhibitors
      • 1.3.6 Steroids
    • 1.4 Market Segment by Application
      • 1.4.1 Global Organ Transplant Immunosuppressant Drugs Market Share by Application (2019-2025)
      • 1.4.2 Bone Marrow Transplant
      • 1.4.3 Heart Transplant
      • 1.4.4 Kidney Transplant
      • 1.4.5 Liver Transplant
      • 1.4.6 Lung Transplant
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Organ Transplant Immunosuppressant Drugs Market Size
      • 2.1.1 Global Organ Transplant Immunosuppressant Drugs Revenue 2014-2025
      • 2.1.2 Global Organ Transplant Immunosuppressant Drugs Sales 2014-2025
    • 2.2 Organ Transplant Immunosuppressant Drugs Growth Rate by Regions
      • 2.2.1 Global Organ Transplant Immunosuppressant Drugs Sales by Regions 2014-2019
      • 2.2.2 Global Organ Transplant Immunosuppressant Drugs Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Organ Transplant Immunosuppressant Drugs Sales by Manufacturers
      • 3.1.1 Organ Transplant Immunosuppressant Drugs Sales by Manufacturers 2014-2019
      • 3.1.2 Organ Transplant Immunosuppressant Drugs Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Organ Transplant Immunosuppressant Drugs Revenue by Manufacturers (2014-2019)
      • 3.2.2 Organ Transplant Immunosuppressant Drugs Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Organ Transplant Immunosuppressant Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.3 Organ Transplant Immunosuppressant Drugs Price by Manufacturers
    • 3.4 Key Manufacturers Organ Transplant Immunosuppressant Drugs Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Organ Transplant Immunosuppressant Drugs Market
    • 3.6 Key Manufacturers Organ Transplant Immunosuppressant Drugs Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Antibodies Sales and Revenue (2014-2019)
      • 4.1.2 Antiproliferative Agents Sales and Revenue (2014-2019)
      • 4.1.3 Calcineurin Inhibitors Sales and Revenue (2014-2019)
      • 4.1.4 mTOR Inhibitors Sales and Revenue (2014-2019)
      • 4.1.5 Steroids Sales and Revenue (2014-2019)
    • 4.2 Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Type
    • 4.3 Global Organ Transplant Immunosuppressant Drugs Revenue Market Share by Type
    • 4.4 Organ Transplant Immunosuppressant Drugs Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Organ Transplant Immunosuppressant Drugs Sales by Application

    6 United States

    • 6.1 United States Organ Transplant Immunosuppressant Drugs Breakdown Data by Company
    • 6.2 United States Organ Transplant Immunosuppressant Drugs Breakdown Data by Type
    • 6.3 United States Organ Transplant Immunosuppressant Drugs Breakdown Data by Application

    7 European Union

    • 7.1 European Union Organ Transplant Immunosuppressant Drugs Breakdown Data by Company
    • 7.2 European Union Organ Transplant Immunosuppressant Drugs Breakdown Data by Type
    • 7.3 European Union Organ Transplant Immunosuppressant Drugs Breakdown Data by Application

    8 China

    • 8.1 China Organ Transplant Immunosuppressant Drugs Breakdown Data by Company
    • 8.2 China Organ Transplant Immunosuppressant Drugs Breakdown Data by Type
    • 8.3 China Organ Transplant Immunosuppressant Drugs Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Organ Transplant Immunosuppressant Drugs Breakdown Data by Company
    • 9.2 Rest of World Organ Transplant Immunosuppressant Drugs Breakdown Data by Type
    • 9.3 Rest of World Organ Transplant Immunosuppressant Drugs Breakdown Data by Application
    • 9.4 Rest of World Organ Transplant Immunosuppressant Drugs Breakdown Data by Countries
      • 9.4.1 Rest of World Organ Transplant Immunosuppressant Drugs Sales by Countries
      • 9.4.2 Rest of World Organ Transplant Immunosuppressant Drugs Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 F. Hoffmann-La Roche Ltd.
      • 10.1.1 F. Hoffmann-La Roche Ltd. Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Organ Transplant Immunosuppressant Drugs
      • 10.1.4 Organ Transplant Immunosuppressant Drugs Product Introduction
      • 10.1.5 F. Hoffmann-La Roche Ltd. Recent Development
    • 10.2 Sanofi
      • 10.2.1 Sanofi Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Organ Transplant Immunosuppressant Drugs
      • 10.2.4 Organ Transplant Immunosuppressant Drugs Product Introduction
      • 10.2.5 Sanofi Recent Development
    • 10.3 AbbVie, Inc.
      • 10.3.1 AbbVie, Inc. Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Organ Transplant Immunosuppressant Drugs
      • 10.3.4 Organ Transplant Immunosuppressant Drugs Product Introduction
      • 10.3.5 AbbVie, Inc. Recent Development
    • 10.4 Allergan plc.
      • 10.4.1 Allergan plc. Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Organ Transplant Immunosuppressant Drugs
      • 10.4.4 Organ Transplant Immunosuppressant Drugs Product Introduction
      • 10.4.5 Allergan plc. Recent Development
    • 10.5 Astellas Pharma, Inc.
      • 10.5.1 Astellas Pharma, Inc. Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Organ Transplant Immunosuppressant Drugs
      • 10.5.4 Organ Transplant Immunosuppressant Drugs Product Introduction
      • 10.5.5 Astellas Pharma, Inc. Recent Development
    • 10.6 Bristol-Myers Squibb Company
      • 10.6.1 Bristol-Myers Squibb Company Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Organ Transplant Immunosuppressant Drugs
      • 10.6.4 Organ Transplant Immunosuppressant Drugs Product Introduction
      • 10.6.5 Bristol-Myers Squibb Company Recent Development
    • 10.7 Hoffmann-La Roche Ltd.
      • 10.7.1 Hoffmann-La Roche Ltd. Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Organ Transplant Immunosuppressant Drugs
      • 10.7.4 Organ Transplant Immunosuppressant Drugs Product Introduction
      • 10.7.5 Hoffmann-La Roche Ltd. Recent Development
    • 10.8 GlaxoSmithKline plc
      • 10.8.1 GlaxoSmithKline plc Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Organ Transplant Immunosuppressant Drugs
      • 10.8.4 Organ Transplant Immunosuppressant Drugs Product Introduction
      • 10.8.5 GlaxoSmithKline plc Recent Development
    • 10.9 Janssen Pharmaceutical
      • 10.9.1 Janssen Pharmaceutical Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Organ Transplant Immunosuppressant Drugs
      • 10.9.4 Organ Transplant Immunosuppressant Drugs Product Introduction
      • 10.9.5 Janssen Pharmaceutical Recent Development
    • 10.10 Novartis AG
      • 10.10.1 Novartis AG Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Organ Transplant Immunosuppressant Drugs
      • 10.10.4 Organ Transplant Immunosuppressant Drugs Product Introduction
      • 10.10.5 Novartis AG Recent Development
    • 10.11 Pfizer, Inc.
    • 10.12 Veloxis Pharmaceuticals

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Organ Transplant Immunosuppressant Drugs Sales Channels
      • 11.2.2 Organ Transplant Immunosuppressant Drugs Distributors
    • 11.3 Organ Transplant Immunosuppressant Drugs Customers

    12 Market Forecast

    • 12.1 Global Organ Transplant Immunosuppressant Drugs Sales and Revenue Forecast 2019-2025
    • 12.2 Global Organ Transplant Immunosuppressant Drugs Sales Forecast by Type
    • 12.3 Global Organ Transplant Immunosuppressant Drugs Sales Forecast by Application
    • 12.4 Organ Transplant Immunosuppressant Drugs Forecast by Regions
      • 12.4.1 Global Organ Transplant Immunosuppressant Drugs Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Organ Transplant Immunosuppressant Drugs Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Solid organ transplantation has been rapidly developed as a therapeutic intervention that is life-saving and greatly contributes to a better quality of life in organ recipients. Organ transplant immunosuppressant drugs can prevent organ rejection post transplantation.
      In 2019, the market size of Organ Transplant Immunosuppressant Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Organ Transplant Immunosuppressant Drugs.

      This report studies the global market size of Organ Transplant Immunosuppressant Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Organ Transplant Immunosuppressant Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      F. Hoffmann-La Roche Ltd.
      Sanofi
      AbbVie, Inc.
      Allergan plc.
      Astellas Pharma, Inc.
      Bristol-Myers Squibb Company
      Hoffmann-La Roche Ltd.
      GlaxoSmithKline plc
      Janssen Pharmaceutical
      Novartis AG
      Pfizer, Inc.
      Veloxis Pharmaceuticals

      Market Segment by Product Type
      Antibodies
      Antiproliferative Agents
      Calcineurin Inhibitors
      mTOR Inhibitors
      Steroids

      Market Segment by Application
      Bone Marrow Transplant
      Heart Transplant
      Kidney Transplant
      Liver Transplant
      Lung Transplant

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Organ Transplant Immunosuppressant Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Organ Transplant Immunosuppressant Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Organ Transplant Immunosuppressant Drugs are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now